Assessment of hepatic VX2 tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imaging

doi:10.3748/wjg.14.3908

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2068)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

204

HTML

1762

Figures (1-3)

102

Sum=2068

Jun 28, 2008 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 28, 2008; 14(24): 3908-3913
Published online Jun 28, 2008. doi: 10.3748/wjg.14.3908

Full Size Figure Download Figure

Figure 3 Videodensitometric measurements of liver normal parenchyma (white), tumor parenchyma (gray) and tumor boundary (black) before and after percutaneous transhepatic injection of contrast agent SonoVue^® into the normal liver parenchyma near the VX₂ tumors during PTL. ^aP < 0.05 vs respective pre-injection values (Dunnett).

Citation: Liu C, Liang P, Wang Y, Zhou P, Li X, Han ZY, Liu SP. Assessment of hepatic VX₂ tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imaging. World J Gastroenterol 2008; 14(24): 3908-3913
URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3908.htm
DOI: https://dx.doi.org/10.3748/wjg.14.3908